Estrogen contributes to the development of three of the top five cancers of women--those of the breast, uterus, and ovaries--which together account for an estimated 240,000 new cancer cases a year in the United States alone (Ref.1). The ER (Estrogen Receptor) signaling pathway is implicated in the progression of cancer tumorigenesis and the activity of the hormone receptor is regulated by ligands (Estrogens), and coactivators or corepressors (Ref.2). MNAR (Modulator of Nongenomic Activity Of Estrogen Receptor)/PELP1 (Pro...
References:
-
Belcher SM.
Brain Res Rev. 2008 Mar;57(2):481-92. Epub 2007 Sep 14. Review.
-
Saha Roy S, Vadlamudi RK.
Int J Breast Cancer. 2012;2012:654698. doi: 10.1155/2012/654698. Epub 2011 Dec 19.
-
Balasenthil S, Vadlamudi RK.
J Biol Chem. 2003 Jun 13;278(24):22119-27. Epub 2003 Apr 7.
-
Mishra SK, Balasenthil S, Nguyen D, Vadlamudi RK.
Gene. 2004 Apr 14;330:115-22.
You can view details of this pathway by subscribing: